Post exposure prophylaxis antibiotics: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Hepatitis B==
==Hepatitis B==
''Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history''<ref> Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e</ref>
{{Hepatitis B post exposure prophylaxis}}
===Unvaccinated===
*If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites
*If source is HGsAG(-) then start the HBV vaccine series
*If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series
**If source blood is low risk and unavailable then begin HBV series
===Previously vaccinated non responder (one series)===
''Non responder status is defined as anti-has <10mIU/mL''
*If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series 
**Can also opt to perform second HBIG administration in one month
*If source is HBsAg(-) then no treatment is needed
*If source blood is unavailable and high risk then treat as if HBsAg(+)
===Previously vaccinated non responder (two series)===
''Non responder status is defined as anti-has <10mIU/mL''
*If the source is HBsAg(+) then give HBIG x2 and no HBV series
*If source is HGsAG(-) then no treatment is needed
*If source blood is unavailable then initiate the HBV series
==See Also==
==See Also==
{{Antibiotics by diagnosis navigation}}
{{Antibiotics by diagnosis navigation}}

Revision as of 16:04, 22 May 2016

Hepatitis B

Hepatitis B Post-Exposure Prophylaxis

Treatment is generally initiated after coordination with occupational health and infectious disease service and based the the exposed patient's vaccination history[1]

Unvaccinated

  • If the source is HBsAg(+) then give HBIG x1 and initiate HBV vaccine in two separate sites
  • If source is HGsAG(-) then start the HBV vaccine series
  • If source blood is unavailable and high risk then give HBIG x1 initiate the HBV series
    • If source blood is low risk and unavailable then begin HBV series

Previously vaccinated non responder (one series)

Non responder status is defined as anti-has <10mIU/mL

  • If the source is HBsAg(+) then give HBIG x 1 and begin revaccination series
    • Can also opt to perform second HBIG administration in one month
  • If source is HBsAg(-) then no treatment is needed
  • If source blood is unavailable and high risk then treat as if HBsAg(+)

Previously vaccinated non responder (two series)

Non responder status is defined as anti-has <10mIU/mL

  • If the source is HBsAg(+) then give HBIG x2 and no HBV series
  • If source is HGsAG(-) then no treatment is needed
  • If source blood is unavailable then initiate the HBV series

Treatment Dosing

No contraindications for pregnancy or breast feeding

  • HBIG 0.06 mL/kg IM
    • Give in opposite arm from hepatitis B vaccine if patient also receiving vaccine
  • Vaccination series: HBV vaccine options:
    • Engerix-B 20mcg IM
    • Recombivax HB 10mcg IM

See Also

Antibiotics by diagnosis

For antibiotics by organism see Microbiology (Main)

References

  1. Postexposure prophylaxis to prevent hepatitis b virus infection. CDC MMWR http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5516a3.htm?s_cid=rr5516a3_e